Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Yang Fan LV"'
Autor:
Xiang-lin Hao, Yang-fan Lv, De-feng Li, Fu-hai Bai, Ji Gong, Guang-qiang Pan, Lin-xi Su, Ya-li Wang, Wan-lei Fu, Bo Liu, Lu Huang, Dong Yan, Qiu-lin Tan, Jin-yi Liu, Qiao-nan Guo
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-23 (2024)
Abstract Background Tandem C2 domains, nuclear (TC2N) is a C2 domain-containing protein that belongs to the carboxyl-terminal type (C-type) tandem C2 protein family, and acts as an oncogenic driver in several cancers. Previously, we preliminarily rep
Externí odkaz:
https://doaj.org/article/6e8f9f700bce4e978f3760dbcebcdb4a
Autor:
Yan, Yang, Lin, Xiao Shi, Ming, Wang Zheng, Chuan, Zhang Qi, Hui, Gan, Juan, Sun Ya, Shuang, Wang, Yang Fan, LV, Dong, Zhang
Publikováno v:
In Academic Radiology March 2024 31(3):859-869
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 9, Iss 1, Pp n/a-n/a (2021)
Abstract Background Clear cell renal cell carcinoma (ccRCC) is an aggressive subtype of renal cell carcinoma. X‐C motif chemokine receptor 1 (XCR1) exerts important roles in tumor progression; however, its role in ccRCC is unclear. Methods We utili
Externí odkaz:
https://doaj.org/article/dda34e63f1db44ce9b930990f6507776
Autor:
Guo-sheng Zhao, Zi-ran Gao, Qiao Zhang, Xue-feng Tang, Yang-fan Lv, Zhao-si Zhang, Yuan Zhang, Qiu-lin Tan, Dong-bin Peng, Dian-ming Jiang, Qiao-Nan Guo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-17 (2018)
Abstract Background Over the last two or three decades, the pace of development of treatments for osteosarcoma tends has been slow. Novel effective therapies for osteosarcoma are still lacking. Previously, we reported that tumor-suppressing STF cDNA
Externí odkaz:
https://doaj.org/article/8f63c68e937341c8b01d3bc59a1349bf
Publikováno v:
Journal of Hepatocellular Carcinoma
Xian Chang,1,* Yang-Fan Lv,2,* Jing He,3,* Ya Cao,2 Chang-Qing Li,1 Qiao-Nan Guo2 1Department of Orthopedics, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, 400037, People’s Republic of China; 2Department
Autor:
Yang-Fan Lv, Qin Ouyang, Kebin Zhang, Meng-Meng Jie, Yang Chen, Xinzhe Li, Shi-Ming Yang, Shuo Zeng, Cheng Liu, Liting Wang, Qian Dai, Chenglin Li, Mengyuan Gao, Changyu Shan, Fengtian He, Chang-Jiang Hu, Yaran Wu, Qingyun Tang
Publikováno v:
Molecular Cancer, Vol 19, Iss 1, Pp 1-16 (2020)
Molecular Cancer
Molecular Cancer
Background Aberrant expression of circular RNAs contributes to the initiation and progression of cancers, but the underlying mechanism remains elusive. Methods RNA-seq and qRT-PCR were performed to screen differential expressed circRNAs between gastr
Autor:
Guo-Sheng Zhao, Zi-ran Gao, Xue-Feng Tang, Dong-bin Peng, Yang-Fan Lv, Ya Cao, Ying Zeng, Qiao-Nan Guo
Publikováno v:
Cancer Management and Research. 11:547-559
Xue-Feng Tang,1 Ya Cao,1 Dong-Bin Peng,1 Guo-Sheng Zhao,2 Ying Zeng,1,3 Zi-Ran Gao,1 Yang-Fan Lv,1 Qiao-Nan Guo1 1Department of Pathology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China; 2Department of Orthopedic Surgery, The Firs
Publikováno v:
Molecular Genetics & Genomic Medicine
Molecular Genetics & Genomic Medicine, Vol 9, Iss 1, Pp n/a-n/a (2021)
Molecular Genetics & Genomic Medicine, Vol 9, Iss 1, Pp n/a-n/a (2021)
Background Clear cell renal cell carcinoma (ccRCC) is an aggressive subtype of renal cell carcinoma. X‐C motif chemokine receptor 1 (XCR1) exerts important roles in tumor progression; however, its role in ccRCC is unclear. Methods We utilized publi
Publikováno v:
Clinical Interventions in Aging
Chao Liu,1,* Jie Hu,1,* Zhi Mao,1,* Hongjun Kang,1 Hui Liu,1 Wanlei Fu,2 Yangfan Lv,2 Feihu Zhou1 1Department of Critical Care Medicine, Chinese People’s Liberation Army General Hospital, Beijing, People’s Republic of China; 2Department of Pathol
Autor:
Guo-Sheng, Zhao, Qiao, Zhang, Ya, Cao, Yang, Wang, Yang-Fan, Lv, Zhao-Si, Zhang, Yuan, Zhang, Qiu-Lin, Tan, Yu, Chang, Zheng-Xue, Quan, Dian-Ming, Jiang, Qiao-Nan, Guo
Publikováno v:
American journal of translational research. 11(4)
A lack of understanding of the molecular basis underlying the regulation of metastatic disease and its effective therapy are the primary causes of high mortality in osteosarcoma. Thus, new insights into metastases and novel effective targets for meta